Stage III Cutaneous Melanoma AJCC v7 Completed Phase 2 Trials for Aflibercept (DB08885)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0091046 (Stage III Cutaneous Melanoma AJCC v7) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01258855 | Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery | Treatment |